Strengthening Patient Safety and Pharmaceutical Supply Chains: A review of Nigeria’s electronic pharmacy regulations 2026

INTRODUCTION

The regulation of pharmacy practice in Nigeria has undergone significant transformation with the increasing integration of digital technologies into healthcare delivery. The rapid growth of telemedicine, electronic prescriptions, and online pharmaceutical services has reshaped how healthcare services are accessed and delivered across the country. Patients can now consult healthcare professionals remotely, receive prescriptions electronically, and obtain medications through digital platforms without physically visiting healthcare facilities. While these innovations have improved convenience and access to healthcare services, they have also created regulatory concerns relating to patient safety, prescription verification, counterfeit medicines, data protection, and pharmaceutical supply chain integrity.

The Pharmacy Council of Nigeria’s Online Pharmacy Regulations 2021 represented an early attempt to regulate internet-based pharmaceutical services, which established a framework for the registration, licensing, and operation of internet-based pharmaceutical service providers. In practice, however, the 2021 framework left material gaps. It did not adequately address electronic pharmacy aggregators, it retained a rigid approach to physical premises, it provided limited guidance on digital prescribing and dispensing, and it imposed broad information and communication technology compliance obligations without sufficient operational detail.

In response to these gaps, the Electronic Pharmacy Regulations 2026 were introduced as a more comprehensive framework for digital pharmaceutical practice in Nigeria. The Regulations seek to modernise electronic pharmacy practice through clearer compliance obligations, expanded regulatory oversight, and stronger patient protection mechanisms.

This article reviews the implications of the Regulations for patient safety, pharmaceutical supply-chain governance and digital-health compliance. It also highlights key implementation risks and practical compliance steps for e-pharmacy operators, aggregators, pharmacists, healthcare providers and regulators.

LEGAL AND REGULATORY FRAMEWORK

In 2021, the Pharmacy Council of Nigeria (“PCN”) introduced the Online Pharmacy Regulations to regulate the online sale of medicines in Nigeria. However, the 2021 framework revealed several gaps, including the absence of regulation for online pharmacy aggregators, rigid requirements for physical premises before registration, unclear dispensing rules and vague ICT compliance obligations. These shortcomings created operational and compliance challenges for digital pharmacy operators.

To address these issues, the Electronic Pharmacy Regulations 2026 introduced a broader and more structured framework for electronic pharmacy practice in Nigeria. The Regulations established two categories of operators: Electronic Pharmaceutical Service Providers (“EPSPs”), which directly sell and dispense pharmaceutical products online, and Electronic Pharmacy Aggregators (“EPAs”), which provide digital platforms connecting consumers with registered pharmacies.

The Regulations also introduced more flexible registration pathways, allowing operators to function through partnerships with licensed pharmacies or aggregator platforms. Nevertheless, all operators must still operate under the supervision of a licensed Superintendent Pharmacist linked to a registered physical premises. Another key innovation is the establishment of the National Electronic Pharmacy Platform (“NEPP”), a centralized system for processing e-pharmacy transactions, improving prescription verification, transaction traceability and data governance.

The regulatory ecosystem remains multi-agency in nature. The PCN regulates pharmacy practice and licensing, NAFDAC oversees medicine registration and quality assurance, the Federal Ministry of Health and Social Welfare provides policy direction, while the Nigeria Data Protection Commission (“NDPC”) regulates the processing of personal and health-related data.

• Registration and Licensing Framework

The Electronic Pharmacy Regulations 2026 seek to strengthen oversight, improve accountability and ensure compliance with professional standards within Nigeria’s evolving e-pharmacy sector.

Under Regulation 3, EPSPs are required to register with the PCN and obtain an Electronic Pharmacy License before commencing operations through websites, mobile applications or other electronic channels. Applicants must submit prescribed corporate and operational documentation, evidence of pharmacist supervision and other compliance materials required by the PCN.

The Regulations also require operators to appoint a Superintendent Pharmacist responsible for regulatory compliance and oversight of pharmaceutical service delivery. This requirement reinforces the principle that pharmaceutical services, irrespective of the delivery model, remain subject to qualified professional supervision and ethical accountability.

• Registration of Electronic Pharmacy Aggregators

A notable innovation under the Regulations is the formal recognition and regulation of Electronic Pharmacy Aggregators (“EPAs”). EPAs are digital platforms connecting consumers with multiple pharmacies through electronic channels. Under Regulation 3, EPAs are required to register with the Pharmacy Council of Nigeria before commencing operations. They are also required to appoint a Superintendent Pharmacist responsible for regulatory compliance and professional oversight.

• Patient Safety Provisions Under the Regulations

The Regulations treat online dispensing as a regulated healthcare service rather than ordinary e-commerce. This distinction is fundamental. A medicine-delivery platform may look like a consumer marketplace, but the underlying transaction involves clinical risk, professional judgment, medicine quality and patient confidentiality.

• Prescription Authentication and Verification

The Regulations impose detailed requirements for prescription authentication and verification. Electronic pharmacy systems must prevent unauthorized access, tampering and interception of prescriptions while ensuring secure transmission and verification of electronic prescriptions and prescriber identities.

A valid prescription must contain essential patient and prescriber information, including medicine details, duration, refill information, registration numbers and healthcare facility details. Providers are prohibited from dispensing prescription-only medicines where prescriptions are incomplete or deficient.

The Regulations also recognize scanned prescriptions and telemedicine-generated prescriptions, reflecting the increasing adoption of digital healthcare services. However, telemedicine prescriptions should still be supported by informed patient consent, proper clinical records, secure communication systems and clear accountability between the prescriber, pharmacist and platform operator.

• Drug Dispensing and Compliance Measures

The Regulations clarify the categories of medicines that may be distributed online, including certain Prescription-Only Medicines granted Over-the-Counter waivers, such as oral contraceptives and family planning products.

Online sale of prescription-only medicines is limited to quantities authorized by the prescription unless otherwise clinically justified. Refill medicines must comply with prescriber instructions, while controlled medicines and dangerous drugs regulated under the Dangerous Drugs Act are excluded from online sale.

Operators are also required to maintain pharmacist-led patient counselling to ensure patients understand the safe use of medications. In addition, delivery obligations require compliance with temperature-control measures, tamper-evident packaging, dispensing labels, audit trails and Good Distribution Practices.

• Identity Verification and Safe Delivery

The Regulations impose identity verification obligations aimed at preventing diversion, fraudulent orders, prescription misuse and unsafe dispensing. Appropriate controls include prescription validation, phone-number verification, patient-information checks and, where necessary, identity-document verification.

Delivery processes must also preserve product integrity through appropriate packaging, temperature control, tamper-evident containers, proof of delivery and audit trails.

• Data Protection and Patient Confidentiality

The Regulations place significant emphasis on data protection and patient confidentiality. E-pharmacy operators routinely process sensitive personal and health-related data, including prescription records, identity details, payment information, contact details and telemedicine records.

Consequently, compliance with the Nigeria Data Protection Act 2023 is essential. Operators must process personal data lawfully, fairly and transparently, collect only data necessary for defined purposes, implement adequate security safeguards, retain data only for justified periods and respect data-subject rights.

To strengthen compliance, operators are advised to maintain comprehensive data-protection compliance documentation, including privacy notices, records of processing activities, data-processing agreements, retention schedules, breach-response procedures, security measures and periodic privacy impact assessments.

IMPLEMENTATION CHALLENGES AND REGULATORY CONCERNS

The effectiveness of the Electronic Pharmacy Regulations 2026 will depend largely on robust enforcement, adequate digital-monitoring systems, trained inspectors and effective inter-agency coordination. Smaller pharmacies may face financial and operational challenges in meeting compliance obligations, making phased compliance measures and technical support necessary. Cybersecurity is also critical, as e-pharmacy platforms process sensitive prescription and health data. Operators should therefore implement strong security measures, including encryption, access controls, vulnerability testing, incident-response procedures and staff training, while complying with data-breach obligations under the Nigeria Data Protection Act. In addition, regulators should issue coordinated guidance on licensing, data-sharing, prescription verification, reporting obligations and sanctions to ensure regulatory clarity and more effective enforcement.

PRACTICAL IMPLICATIONS FOR OPERATORS AND INVESTORS

Given the technical and multi-regulatory nature of the new framework, e-pharmacy operators, aggregators, telemedicine platforms, healthcare providers and investors should undertake a structured compliance assessment to determine the approvals, governance controls, contractual protections, data-protection measures and operational safeguards required for their business model. Legal and regulatory support will be critical in helping businesses interpret the Regulations, engage with relevant regulators, update internal policies and contracts, conduct compliance audits, manage enforcement exposure and design practical implementation roadmaps that align with both commercial realities and patient-safety obligations.

CONCLUSION

The Electronic Pharmacy Regulations 2026 represent an important step toward improving patient safety, strengthening medicine-supply integrity and regulating digital pharmaceutical services in Nigeria. The framework recognises aggregators, preserves pharmacist supervision and enhances prescription verification and traceability through the NEPP. However, effective implementation will require coordinated enforcement, cybersecurity investment and stakeholder engagement. E-pharmacy operators and aggregators should therefore confirm the applicable PCN approval pathway, appoint a Superintendent Pharmacist, implement prescription-verification and cybersecurity controls, onboard only licensed partners, strengthen supplier-authenticity and delivery processes, establish complaint and breach-response procedures, maintain data-protection compliance measures and train staff on applicable regulatory and ethical obligations.

Francisca Igboanugo is a Team Lead in the Health & Pharmaceutical Sector at Stren & Blan Partners, while Emmanuel Ughanze, Confidence Edeh, Onapina Aipoh and Obinna Odikaesieme are Associates in the same sector.

Stren & Blan Partners is a full-service commercial Law Firm that provides legal services to diverse local and international Clientele. The Business Counsel is a weekly column by Stren & Blan Partners that provides thought leadership insight on business and legal matters.

Connect with Stren & Blan Partners:

Email: [email protected]

Website: www.strenandblan.com

LinkedIn: linkedin.com/company/strenandblan

Twitter: twitter.com/Strenandblan

Instagram: instagram.com/strenandblan